The efficacy, pharmacokinetics, safety and cardiovascular risks of switching nevirapine to rilpivirine in HIV-1 patients: the RPV switch study

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)181-182
Number of pages2
JournalJournal of the International AIDS Society
Volume17
DOIs
Publication statusPublished - 2014

Cite this